Aurora Cannabis Inc.

Aurora Cannabis Inc.

Aurora Cannabis Inc. is a world-renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard.
Medical Marijuana State Programs
Company Details
Drug Manufacturers - Specialty & Generic
Fiscal year-end
June 30
Vancouver, BC
Number of Patients
67,484 at 9/30/18
Financials (Pro Forma 6/30)
Cash on hand
Fixed investment
Shareholders’ equity
$4.40 billion
Revenues – last quarter
Adj. gross margin
Capital Structure
Capital structure
Last financing
Last Equity Fin $345mm Convertible Notes at US$7.23
Basic shares
Diluted shares

Aurora Cannabis Inc. News

11 hours ago

Better Buy: Aurora Cannabis vs. Gilead Sciences

Between this unlikely pair, which stock is the better pick for long-term investors?

14 Jun

Aurora Cannabis - More Massive Dilution Inevitable For This Train Wreck

Aurora Cannabis Inc. ( ACB ) has received a lot of attention from analysts of late. However, no one has seemed to focus on a glaring red flag for the company. This article concentrates on the fact of costs...

14 Jun

Vietnam May Be Booming, but It Remains a Frontier Market

The fuel for this Southeast Asian country is its export economy and young workforce. But while it may steal some production from China in a trade war, a faltering global economy will hurt. And stocks are...

14 Jun

Aurora Cannabis: Big Money Is Flowing In

The future prospects of Aurora Cannabis ( ACB ) have been a subject of several discussions across various investing forums of late. There's the general concern that growing output too much too fast would...

13 Jun

Aurora Still Faces Black-Market Competition

Intro: According to a recent study conducted by Scotiabank , 71% of Canadian marijuana users purchased their product from an illegal source, but by 2020, they believe this will fall to only 37%. This...

13 Jun

Medical Products Industry Outlook: Growth Prospects Radiant

Medical Products Industry Outlook: Growth Prospects Radiant

12 Jun

Why Aurora Cannabis (ACB) Will Perform Well Against Low-Cost Latin Competitors

Some investors have been raising concerns over the potential disruption of the cannabis market in general with low-cost pot produced in Latin America flooding the market, and in some cases, specifically...

11 Jun

This Marijuana Stock Toppled Apple As No. 1 Among Millennial Investors

Cannabis investing emerged as a clear trend in the past year, with marijuana stocks accounting for a fifth of the 20 most-held stocks on the Robinhood app.

11 Jun

Aurora Cannabis (ACB) Is Betting Big on Innovation

By Departures CapitalAurora Cannabis (ACB) has been on an incredible ride the past few years. From humble beginnings into the second-largest Canadian cultivator by market cap, Aurora has really cemented...

10 Jun

'The full Willy Wonka tour:' Inside weed company Cresco's production house

If you have doubts that cannabis is on its way from illegal to industrial, take a look inside Cresco Labs’ custom built, 43-thousand square-foot production facility in Joliet, Illinois.

Load more

About Aurora Cannabis Inc.

Aurora is one of the world’s largest and fastest growing cannabis companies. Following the acquisition of MedReleaf, the company has more than 1,500 employees, 11 facilities, and a funded annual production capacity of more than 500,000 kilograms per year. The Company is vertically integrated and horizontally diversified across every key segment of the cannabis value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company’s purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. Aurora’s growing constellation of subsidiaries and strategic partnerships provide differentiation in terms of geographic reach, production, technology, product offering, and execution.

With a growing number of countries adopting medical cannabis legislation, the Company has embarked on an aggressive international expansion strategy that currently sees Aurora with operations and/or sales in 22 countries across five continents.

"Through our wholly owned subsidiaries, strategic investments, and global partnerships, Aurora provides a wide range of premium quality cannabis and hemp products and services, develops innovative technologies, promotes cannabis consumer health and wellness, and delivers an exceptional customer experience across all its brands.

Aurora’s operations span multiple continents and focuses on both the medical and recreational cannabis production and sales, patient education and clinic counselling services, home hydroponic cultivation, extraction technologies and delivery systems, and hemp-based food health products.

We operate around the globe pursuing new and emerging cannabis markets where possible through our owned network of import, export and wholesale distributors, and our e-commerce and mobile applications."

Corporate Governance

Aurora Cannabis Inc.’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 9; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Features Aurora Cannabis Inc.

Canadian Operations

  • Multiple state-of-the-art facilities in operation or under construction in four provinces
  • Recent acquisitions of CanniMed and MedReleaf leave the company with nine facilities in Canada
  • Ownership of CanvasRx, the largest operator of cannabis clinics in Canada with 35 clinics open
  • Strong product portfolio with Aurora, CanniMed, and MedReleaf brands and wellness brands including San Rafael ’71, Woodstock, and AltaVie
  • Same-day delivery in Alberta and innovative mobile ordering app
  • Supply agreements with 12 provinces and territories
  • Agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart to distribute and sell medical cannabis
  • 40 clinical studies completed or ongoing
  • Large investment portfolio including TGOD, Radient Technologies, Hempco, Alcanna (formerly Liquor Stores N.A.), and more

Global Operations

  • Active in five continents and 22 countries
  • 22.9% ownership of Australia’s Cann Group (ASX: CAN)
  • 51% ownership of Aurora Nordic in Denmark
  • Ownership of German distribution company Pedanios
  • Wholly owned subsidiary ICC Labs gives the company a platform in Latin America
  • Acquired European hemp company Agropro and sister company Borela
  •  Supply agreements in Italy, South Africa, Luxembourg, and Mexico
  • Import permit from the Polish Ministry of Health
  • Approved for the first cannabis cultivation facility in Malta
  • Structured investment in spin-off Australis Capital, which positions the company to benefit from eventual U.S. legalization


Terry Booth
Founder, CEO
Mr. Stephen Dobler
Founder, Pres & Director
Glen Ibbott
Chief Financial Officer

Participation in events


Edmonton Alberta, Canada
31 Mar 2019
Medicine Hat Alberta, Canada
12 Feb 2019
$ 7.56
Share volume:
2.523 M
Total value:
19.436 M
Market cap:
7.659 B

Hours (MST)

6:00 - 18:00

Closed now

6:00 - 18:00
6:00 - 18:00
6:00 - 18:00
6:00 - 18:00